Mantilla Daniel E, D Vera Daniela, Ortiz Andrés F, Nicoud Franck, Costalat Vincent
Interventional Radiology Department, Fundación oftalmológica de Santander - Clínica Ardila Lülle, Floridablanca, Colombia.
Interventional Radiology Department, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
Interv Neuroradiol. 2023 Sep 11:15910199231201544. doi: 10.1177/15910199231201544.
This study is a systematic review about the WEB device and addresses the efficacy and safety of this device for the endovascular treatment of ruptured and unruptured intracranial aneurysms.
This systematic literature review followed PRISMA-P guidelines and included studies published until 2010. PubMed and ScienceDirect databases were searched, resulting in 22 articles meeting the inclusion criteria.
The studies involved 1705 patients and 1224 aneurysms, predominantly wide-neck aneurysms in the middle cerebral artery, internal carotid artery, and basilar artery. The treatment success rate was 28.1%, with the WEB-SL and WEB-SLS devices being commonly used. The immediate post-treatment adequate occlusion rate was 33.3%, increasing to 49.7% at follow-up. Thromboembolic complications occurred in 6.5% of cases, while other complications were observed in 3.1% of cases. The mortality rate associated with the WEB device was low, approximately 1%.
The WEB device demonstrates favorable outcomes in treating patients with intracranial aneurysms, with adequate occlusion rates improving over time. Thromboembolic complications are the primary concern, but overall complication and mortality rates remain low. Further research is needed to optimize device selection, standardize classification systems, and enhance long-term evaluation and training protocols.
本研究是关于WEB装置的系统评价,探讨该装置用于破裂和未破裂颅内动脉瘤血管内治疗的有效性和安全性。
本系统文献综述遵循PRISMA-P指南,纳入截至2010年发表的研究。检索了PubMed和ScienceDirect数据库,共筛选出22篇符合纳入标准的文章。
这些研究共涉及1705例患者和1224个动脉瘤,主要为大脑中动脉、颈内动脉和基底动脉的宽颈动脉瘤。治疗成功率为28.1%,常用的装置为WEB-SL和WEB-SLS。治疗后即刻完全闭塞率为33.3%,随访时增至49.7%。血栓栓塞并发症发生率为6.5%,其他并发症发生率为3.1%。与WEB装置相关的死亡率较低,约为1%。
WEB装置在治疗颅内动脉瘤患者方面显示出良好的效果,完全闭塞率随时间推移有所提高。血栓栓塞并发症是主要关注点,但总体并发症和死亡率仍然较低。需要进一步研究以优化装置选择、规范分类系统并加强长期评估和培训方案。